ICI hires three advisers for rights issue

Merrill Lynch, UBS Warburg and Goldman Sachs are all working for UK-based Imperial Chemical Industries on its planned rights issue.

The three banks are joint brokers and advisers on the issue that, net of proceeds, should bring in about £800m (€1.3bn) for ICI. In addition, ICI plans to divest Synetix, its catalyst business, although as yet it is not clear who will be advising the company on the sale.

WSJ Logo
Spectris Agrees to $5.64 Billion KKR TakeoverExternal link

Spectris Agrees to $5.64 Billion KKR Takeover